Chiron Investments

Chiron Investment Management is a multi-asset investment firm that applies a quantitative and fundamental approach to global investing, with a significant focus on the healthcare and life sciences sectors. Founded in 2015, the firm utilizes a proprietary investment process that integrates behavioral finance with rigorous fundamental analysis to identify opportunities across various market cycles. While not a drug developer itself, Chiron is a prominent investor in the biotechnology and pharmaceutical industries, providing capital to companies ranging from early-stage startups to established healthcare giants. In 2020, the firm was acquired by FS Investments, expanding its reach and resources within the alternative investment space. Chiron continues to operate as a specialized investment team, leveraging its expertise to navigate the complexities of the global healthcare market.